Vince (VNCE) Issues Earnings Results

Share on StockTwits

Vince (NYSE:VNCE) announced its quarterly earnings results on Thursday. The textile maker reported ($0.49) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.40), Bloomberg Earnings reports. Vince had a negative return on equity of 387.17% and a net margin of 21.50%.

Vince traded up $0.21, reaching $13.90, during trading hours on Thursday, MarketBeat reports. The stock had a trading volume of 202,271 shares, compared to its average volume of 32,887. Vince has a 52 week low of $3.20 and a 52 week high of $14.35. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.81 and a quick ratio of 0.72.

Separately, ValuEngine raised shares of Vince from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd.

Vince Company Profile

Vince Holding Corp. engages in the design, merchandise, and sale of various luxury brand products in the United States and internationally. It operates through two segments, Wholesale and Direct-To-Consumer. The company offers a range of women's products, such as cashmere sweaters, silk blouses, leather and suede leggings and jackets, dresses, denims, pants, tanks, T-shirts, handbags, and outerwear under the Vince brand; and men's products comprising T-shirts, knit and woven tops, sweaters, denim, pants, blazers, outerwear, and leather jackets under the Vince brand.

Earnings History for Vince (NYSE:VNCE)

Receive News & Ratings for Vince Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vince and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Axiom Price Reaches $0.0078 on Exchanges
Axiom Price Reaches $0.0078 on Exchanges
Starta Hits 24-Hour Trading Volume of $0.00
Starta Hits 24-Hour Trading Volume of $0.00
Zacks: Brokerages Expect MTS Systems Co.  Will Announce Earnings of $0.63 Per Share
Zacks: Brokerages Expect MTS Systems Co. Will Announce Earnings of $0.63 Per Share
Obalon Therapeutics  Getting Somewhat Positive Media Coverage, Study Shows
Obalon Therapeutics Getting Somewhat Positive Media Coverage, Study Shows
Novus Therapeutics  Receives News Impact Score of 0.16
Novus Therapeutics Receives News Impact Score of 0.16
$4.68 Earnings Per Share Expected for Regeneron Pharmaceuticals Inc  This Quarter
$4.68 Earnings Per Share Expected for Regeneron Pharmaceuticals Inc This Quarter


Leave a Reply

 
© 2006-2018 Zolmax.